Liver Cancer Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who have chronic hepatitis or mild, stable liver cirrhosis caused by the hepatitis D virus (HDV)
• People who have tested positive for HDV in their blood within the 24 weeks before joining the trial
• People who are already taking antiviral medication for hepatitis B (HBV) at the time of joining
• People who have been prescribed the medication Bulevirtide 2 mg for the first time within 30 days before joining
• People of Caucasian ethnicity
• People aged 18 years or older
• People who eat a normal, balanced diet that includes both plant and animal foods
• People who have not taken antibiotics, probiotics, or prebiotics in the month before joining
• People who have read and signed a consent form agreeing to take part in the trial

Who may not be able to join:

• People whose liver cirrhosis is at an advanced or decompensated stage (meaning the liver is no longer able to function adequately)
• People whose liver condition is not caused by a hepatitis B and D co-infection
• People aged 18 years or younger
• People who are pregnant or breastfeeding
• People who have a serious illness that significantly shortens life expectancy, such as certain cancers, severe heart failure, or severe chronic lung disease
• People with conditions such as coeliac disease or chronic inflammatory bowel disease, or who are taking medications such as antibiotics, probiotics, or prebiotics, that could affect the balance of bacteria in the gut

Important: Always verify eligibility with the trial site directly before applying.